This post is from a suggested group
Nanobots and the Oncology Revolution: Advancements in Targeted Drug Delivery and Precision Diagnostics for Cancer Treatment in East Asia
One of the most transformative applications of nanorobotics in the Asia Pacific is its potential to revolutionize oncology through targeted drug delivery systems. Traditional chemotherapy is highly toxic because it non-selectively destroys both cancerous and healthy cells, leading to severe side effects and often limiting the therapeutic dose that can be administered. Nanobots, however, are being engineered with the capacity to deliver powerful chemotherapeutic agents directly to the tumor site, minimizing systemic exposure and preserving healthy tissue. This highly localized approach is facilitated by the Enhanced Permeability and Retention (EPR) effect, where nanoparticles accumulate selectively in the leaky vasculature of tumor vessels. Nanoparticles like liposomal formulations, such as Doxil and Abraxane, already represent initial steps in this direction, reducing toxicity and improving treatment efficacy. Researchers are now developing more sophisticated nanorobots…




